A carregar...
Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients
Concurrent chemoradiation therapy (CCRT) is the treatment of choice for locally advanced non-small cell lung cancer (LA-NSCLC). Several clinical trials that combine programmed cell death 1 (PD-1) axis inhibitors with radiotherapy are in development for patients with LA-NSCLC. However, the effect of...
Na minha lista:
Publicado no: | Sci Rep |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Nature Publishing Group UK
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5595796/ https://ncbi.nlm.nih.gov/pubmed/28900290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-11949-9 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|